Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells
Keywords: Acla; aclarubicin/aclacinomycin A; CCCP; carbonyl cyanide-m-chlorophenylhydrazone; DMSO; dimethyl sulfoxide; FCCP; carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; OCR; oxygen consumption rate; Aclarubicin; Anthracycline; Chemotherapy; Mitochondria; An